genedrive plc (LON:GDR – Get Free Report) traded up 12.4% during trading on Tuesday . The stock traded as high as GBX 0.57 ($0.01) and last traded at GBX 0.50 ($0.01). 11,823,286 shares traded hands during trading, a decline of 37% from the average session volume of 18,904,068 shares. The stock had previously closed at GBX 0.45 ($0.01).
genedrive Stock Performance
The company has a market capitalization of £4.92 million, a price-to-earnings ratio of -0.22 and a beta of -0.04. The stock has a 50-day moving average price of GBX 0.49 and a 200-day moving average price of GBX 1.06. The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Recommended Stories
- Five stocks we like better than genedrive
- Investing in Construction Stocks
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Why is the Ex-Dividend Date Significant to Investors?
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
